Sign in

What researchers published on Metastatic breast cancer

30,326 papers, newest first.

Showing 140 of 30,326

  • CDK4/6 Inhibitors and Endocrine Therapy in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Multicenter Real-World Cohort.World journal of oncology
  • Systematic reviewEffects of exercise interventions on cancer-related fatigue and quality of life in patients with metastatic breast cancer: a systematic review and meta-analysis.Frontiers in oncology
  • ReviewTargeting the PI3K/AKT/mTOR pathway in endocrine-resistant, hormone receptor-positive, HER2-negative, advanced breast cancer.EClinicalMedicine
  • Case reportRibociclib-induced vitiligo-like depigmentation in a patient with metastatic breast cancer.Dermatology online journal
  • Designing a Locally Adapted Kader Educational Program to Improve Social Support for Women with Metastatic Breast Cancer in Indonesia.Journal of cancer education : the official journal of the American Association for Cancer Education
  • Identifying Distant Breast Cancer Recurrence: A Proof-of-Concept Comparison of Discrete-Field Algorithm and Large Language Model Performance and Cost.JCO clinical cancer informatics
  • Case report[A Case of Pulmonary Metastatic Recurrence of PD-L1-Positive Adenoid Cystic Carcinoma of the Breast Treated with an Immune Checkpoint Inhibitor].Gan to kagaku ryoho. Cancer & chemotherapy
  • Metastasis-directed therapy for oligoprogressive metastatic breast cancer: a review of current evidence and future research priorities.Annals of palliative medicine
  • Meta-analysisOutcome-specific differences between randomized trials and real-world studies of CDK4/6 inhibitors in hormone receptor-positive, HER2-negative advanced breast cancer: a meta-epidemiological analysis.BMC cancer
  • Associations of peripheral neuropathy with patient-reported outcome (PRO) measures in women with breast cancer: from pre-chemotherapy to three or more years post chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Case report[A Case of Multidisciplinary Therapy for Oligometastatic Breast Cancer].Gan to kagaku ryoho. Cancer & chemotherapy
  • Single-cell multiomics profiling reveals tumour microenvironment landscape and sex-specific immune-suppressive feature in male breast cancer.Clinical and translational medicine
  • Comparison of five definitions of meaningful change on patient-reported outcomes in four SWOG clinical trials.Journal of patient-reported outcomes
  • ReviewERα-Targeting PROTACs in Breast Cancer: Structural Design, Biological Mechanisms, Clinical Translation, and Implications for Multimodal Management.Critical reviews in oncology/hematology
  • Exploring women's perceptions of climate-related environmental stressors and their influence on palliative care experiences and quality of life among women with breast cancer in Ghana: a qualitative descriptive study.BMC palliative care
  • Dual-database pharmacovigilance analysis based on FAERS and JADER combined with network pharmacology to explore fulvestrant-associated respiratory toxicity.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Advanced Breast Cancer Patients Treated with Trastuzumab Deruxtecan: A Real-World Study.Journal of clinical medicine
  • Meta-analysisSurvival benefit of adding carboplatin to standard anthracycline-taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis.Breast cancer research and treatment
  • Real-World Implementation of Molecular Testing and Biomarker-Guided Therapies in HR+/HER2- Metastatic Breast Cancer.Cancers
  • Time to maximal response of trastuzumab deruxtecan in patients with HER2-Positive metastatic breast cancer: A multicenter retrospective study (TRACE).Breast (Edinburgh, Scotland)
  • Early Magnetic Resonance Imaging and Single-Photon Emission Computerized Tomography Detection of Breast Cancer With Netrin-1-Specific Molecular and Liposome Probes.ChemMedChem
  • An EO771-Derived Metastatic Breast Cancer Model Exhibits RANKL-Associated Osteoimmune Remodeling Before Detectable Bone-Marrow Dissemination.Biology
  • ReviewRechallenge, switch, or target? navigating advanced breast cancer after adjuvant CDK 4/6 inhibitors.Breast cancer research and treatment
  • Prognostic Value of Metabolic-Muscle Reserve Index in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.Journal of clinical medicine
  • Survival Differences Between De Novo and Recurrent HER2-Positive Metastatic Breast Cancer: A Systematic Review and Meta-Analysis.Oncology
  • A Novel Function of Tubulin β2a and Tubulin β3 in Regulating Metastatic Properties in Bone-Metastatic Breast Cancer Cells.Cancers
  • ReviewNavigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • KLRB1 (CD161) as a context-dependent prognostic marker in breast cancer: An exploratory analysis of CD4+ memory T cell infiltration: a retrospective multi-cohort study.Medicine
  • Addition of tucatinib to trastuzumab/pertuzumab after local therapy for isolated intracranial progression in HER2-positive metastatic breast cancer: primary results of the phase II BRIDGET trial.ESMO open
  • Pyramid-level training with stain normalization for breast cancer lymph-node metastasis segmentation in whole-slide images.PloS one
  • Phosphatidylserine modulation influences syncytia formation in human breast cancer cell lines.BMC cancer
  • Case reportCase report: Fournier's gangrene occurring after inavolisib-induced hyperglycemia in a patient with metastatic breast cancer.Frontiers in pharmacology
  • Otological manifestations of disseminated metastatic breast cancer presenting with facial nerve palsy, tinnitus and otalgia.BMJ case reports
  • Metachronous gastric adenocarcinoma during sustained control of metastatic breast cancer.Revista espanola de enfermedades digestivas
  • ReviewCellular/Molecular-assisted Early Detection of Breast Cancer: An Update.Anti-cancer agents in medicinal chemistry
  • CT-defined sarcopenia and outcomes in HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors.Frontiers in medicine
  • Cost-effectiveness of inavolisib plus palbociclib/fulvestrant versus palbociclib/fulvestrant for PIK3CA-mutated advanced breast cancer in China.Frontiers in pharmacology
  • Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
  • Patterns of metastasis according to germline BRCA1/2 mutation status in patients with HER2-negative metastatic breast cancer.Breast cancer research : BCR
  • Ultra-sensitive MRD assessment in long-term complete responders to anti-HER2 therapy in HER2-positive metastatic breast cancer: initial results from HER2-CR study.ESMO open
  • Effect of different axillary management strategies on survival in elderly patients (≥70 Years) with early-stage breast cancer and 1-2 positive lymph nodes, stratified by risk factors.PloS one
  • High-Purity Magnetic Fluidic Isolation of Viable Circulating Tumor Cells Enables Single-Cell Multi-Omics Profiling.Analytical chemistry
  • Potential prognostic value of the free T3/T4 ratio in HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.BMC cancer
  • Interpreting EORTC CAT Core short-form scores in metastatic breast cancer: EQ-VAS-associated cut-points and comparison with published thresholds for clinical importance.Journal of patient-reported outcomes
  • Analytical and clinical validation of Ion Torrent™ Oncomine™ Dx Express Test for identifying PIK3CA/AKT1/PTEN-altered tumors in patients with hormone receptor-positive advanced breast cancer for treatment with capivasertib.Translational oncology
  • CD39-associated myeloid-T-cell coordination within an immunoregulatory neighborhood linked to treatment resistance in triple-negative breast cancer.Breast cancer research : BCR
  • Real-world outcomes of everolimus-based therapy after CDK4/6 inhibitor therapy in ER-positive/HER2-negative metastatic breast cancer: a multicenter registry-based study.Breast cancer (Tokyo, Japan)
  • Case reportBreast metastasis from BRCA1-mutated ovarian cancer: response to parp inhibition and a potential lymphatic route.BMC women's health
  • Dual Primary Malignancies in Breast Cancer: Clinical Characteristics and Survival Predictors Among Hakka Women in Meizhou.Breast cancer (Dove Medical Press)
  • Case reportSequential Anti-HER2 (Human Epidermal Growth Factor Receptor 2) Therapy and Late-Line Tucatinib in Patients With HER2-Positive Breast Cancer and Brain Metastases: A Real-World Case Report.Cureus
  • TP53 shapes tumour-specific immune phenotypes across breast, colorectal and kidney human cancers.Journal of molecular medicine (Berlin, Germany)
  • ReviewMechanotransduction in breast cancer and implications for preclinical modeling.Cancer metastasis reviews
  • FOSL2 expression in histologically diagnosed breast cancer: first immunohistochemical evidence from Cameroon.BMC cancer
  • Case reportExperience with pyrotinib monotherapy for advanced HER2-positive breast cancer with diffuse hepatic metastases and severe hepatic dysfunction: a case report.International journal of surgery case reports
  • ReviewMitochondrial Calcium Signaling Acts in the Regulation of Quiescence in Estrogen Receptor-Positive Breast Cancer.The Yale journal of biology and medicine
  • Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer.Signal transduction and targeted therapy
  • Meta-analysisSequencing trastuzumab deruxtecan and sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis.European journal of clinical pharmacology
  • Molecular and clinical predictors of NAC response and relapse in HR+/HER2- early breast cancer.Breast cancer research : BCR
  • Case reportSuccessful Trastuzumab Desensitization After a Severe Infusion-Related Reaction with Acute Hypoxemia and Suspected Pulmonary Toxicity in HER2-Positive Metastatic Breast Cancer: A Case Report.Cancer management and research
  • Meta-analysisPertuzumab in HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials.Breast cancer research and treatment
  • Chemoendocrine therapy versus tamoxifen with ovarian function suppression in women with node-positive breast cancer.Breast cancer research and treatment
  • ReviewBrain Metastasis of Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies.The breast journal
  • Case reportOrganoid-Guided Precision Salvage Therapy for Advanced Breast Cancer with Multiple Metastases: A Case Report.International journal of women's health
  • Imlunestrant as Monotherapy or in Combination with Abemaciclib in ER+, HER2- Advanced Breast Cancer: Chinese Subgroup Analysis of the Phase III Randomized EMBER-3 Study.Targeted oncology
  • Real-world patient experiences in HR+/HER2- metastatic breast cancer: a study of symptom and side effect reporting by patients and physicians.Breast cancer research and treatment
  • Subtype conversion and metastatic timing in breast cancer liver metastasis.World journal of surgical oncology
  • Randomised trialCardioprotective Effects of Low-Dose Bisoprolol Against Anthracycline-Induced Subclinical Cardiotoxicity in Breast Cancer: A Triple-Blind Randomized Controlled Trial Using Advanced Echocardiographic Parameters.Iranian journal of medical sciences
  • PreprintFORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patients.medRxiv : the preprint server for health sciences
  • PreprintBreast Cancer Evaluation and Targeted Investigational Therapy (BEAT-IT): A Pilot Prospective Tissue-Testing Study for Breast Cancer Clinical Trial Enrollment.Research square
  • Multicenter Retrospective Study of the Impact of Localized Therapy on Prognosis in Patients With Oligometastatic Solid Tumors.Cancer medicine
  • PreprintPhase II study of pembrolizumab plus nab-paclitaxel in Hormone Receptor-positive, HER2- negative metastatic breast cancer: clinical and molecular insights into response.Research square
  • Efficacy and Safety of Datopotamab Deruxtecan From a Single-Institution Experience in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody-Drug Conjugates.Cancer medicine
  • Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study.Translational cancer research
  • Development of an algorithm to support cancer registry registration by identifying patients with metachronous metastases after primary breast cancer.ESMO real world data and digital oncology
  • ReviewTwo Niches, One Disease: Brain and Leptomeningeal Metastases in Breast Cancer: A Narrative Review.Breast cancer (Dove Medical Press)
  • PreprintEvasion of Hepatic ILC1 Immunosurveillance Drives Breast Cancer Liver Metastasis.bioRxiv : the preprint server for biology
  • Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 - metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study.Breast cancer (Tokyo, Japan)
  • 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice-Commentary Based on a Virtual Focus Group.Clinical breast cancer
  • Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05.Future oncology (London, England)
  • Male breast cancer in Northern Tanzania: Clinicopathology and predictors of two-year survival (2016-2022).PloS one
  • Preclinical Evaluation of cRGD-Functionalized Lipid-Polymer Hybrid Nanocarriers for Anti-VEGF Gene Therapy in Triple-Negative Breast Cancer.Drug development research
  • Magnetic Resonance Imaging and Mammography Outcomes by Advanced Breast Cancer Risk.JAMA network open
  • Claudin-1 re-expression as a therapeutic strategy in Triple-negative breast cancer: transcriptional regulation.Molecular biology reports
  • PreprintTargeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy.bioRxiv : the preprint server for biology
  • ReviewImmune remodeling of breast tumor-draining lymph nodes: antigen-presenting cell dysfunction, regulatory T-cell expansion, and premetastatic niche formation.Frontiers in immunology
  • Treatment outcomes and quality of life with palbociclib in patients with advanced breast cancer who also have other medical conditions: a plain language summary of findings from POLARIS.Future oncology (London, England)
  • Case reportAnti-trophoblast Cell-Surface Antigen 2 (TROP2)-Based Therapy for Concurrent Breast and Thyroid Malignancies.Cureus
  • Case reportCase Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma.Frontiers in oncology
  • ReviewHepatic surgery for breast cancer liver metastases in the modern systemic therapy era: narrative review of evidence, patient selection, and a multidisciplinary decision framework.Chinese clinical oncology
  • ReviewBeyond Metastatic Lymphadenopathy in Breast Cancer: Approach to Axillary Masses.Radiographics : a review publication of the Radiological Society of North America, Inc
  • Circulating blood microbiome biomarkers as liquid biopsy in breast cancer.Journal of experimental & clinical cancer research : CR
  • Clinical impact of second radiotracer injection after failed lymphoscintigraphy in breast cancer sentinel lymph node biopsy: a retrospective cohort study.World journal of surgical oncology
  • Evolving First-Line Treatment Strategies in ERBB2-Positive Metastatic Breast Cancer: A Review.JAMA oncology
  • TFAP2A promotes the stemness and metastasis of luminal B/HER2-positive and triple-negative breast cancer cells by enhancing KDM4B transcriptional activity.Molecular biology reports
  • Case reportAPOBEC3 Hypermutation Detection in Metastatic Breast Cancer via Targeted Next-Generation Sequencing.Journal of breast cancer
  • Reproducibility of 18F-FDG PET/CT-based tumour and nodal target delineation in stage II-III breast cancer.Radiation oncology (London, England)
  • Trial resultEribulin mesylate in combination with ivonescimab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer(EMIT): study protocol for a single-arm, multicenter clinical trial.Frontiers in immunology
  • ReviewLocoregional Approaches for Breast Cancer Liver Metastases: A Review.Journal of gastrointestinal cancer
  • Determinants of synchronous and metachronous metastatic breast cancer (2000-2024)-an analysis based on data from German cancer registries.Journal of cancer research and clinical oncology
  • Case report[Sustained disease control with sacituzumab govitecan in a patient with HR+/HER2- metastatic breast cancer resistant to endocrine therapy, with a high tumour burden and limited benefit from standard chemotherapy.].Recenti progressi in medicina
  • Body composition at diagnosis: a key determinant of tumor metabolism and cardiometabolic health in breast cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Verification of a previously obtained EQA based MUC1/CA15-3 harmonisation procedure.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • Case reportA rare neurological adverse event of palbociclib: a chronic inflammatory demyelinating polyneuropathy (CIDP) mimic.Breast cancer research and treatment
  • Case report[Efficacy of sacituzumab govitecan following treatment with trastuzumab deruxtecan in a patient with HR-positive/HER2-low metastatic breast cancer.].Recenti progressi in medicina
  • Case report[CDK4/6 inhibitor to antibody-drug conjugates in HER2-low metastatic breast cancer: sequential therapeutic management of a case report.].Recenti progressi in medicina
  • Clinical significance of extranodal extension in mastectomy patients with limited sentinel lymph node macrometastases: a retrospective cohort study.World journal of surgical oncology
  • Case reportRefractory Hypocalcemia Induced by Denosumab and Nab-Paclitaxel in a Patient With Metastatic Breast Cancer.AACE endocrinology and diabetes
  • Case report[Cervical lymph node metastasis as the initial presentation of poorly differentiated esophageal carcinoma mimicking breast origin: a diagnostic challenge].Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
  • Novel therapies create potential new options for patients with advanced breast cancer: First-line sacituzumab govitecan plus pembrolizumab may improve long-term outcomes for patients with advanced triple-negative breast cancer, whereas the new CDK4/6 inhibitor fovinaciclib shows promising efficacy.Cancer
  • ReviewSafety-guided selection of CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer: toxicity profiles, dose modification, and clinical risk-benefit considerations.Therapeutic advances in drug safety
  • ReviewEfficacy and safety of palbociclib in older women with advanced HR-Positive/HER2-negative breast cancer: a systematic review and meta-analysis.Expert opinion on pharmacotherapy
  • Camizestrant (Etcamah®): an oral estrogen receptor degrader and estrogen receptor antagonist approved for breast cancer.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
  • Identification of YL064 as a novel inhibitor of ATXN3 to suppress tumor growth and metastasis by promoting degradation of oncogenic substrates.Cell death & disease
  • Circulating FABP4 promotes obesity-associated breast cancer lung metastasis through PIP2.Cell reports
  • Venous thromboembolism after breast cancer surgery: incidence, predictive factors and outcomes in 270,564 patients.Breast cancer research and treatment
  • Nanocatalytic Immunotherapy Targeting Tumor-Resident Intracellular Bacteria for Triple-Negative Breast Cancer Treatment and Metastasis Suppression.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
  • Single-Cell Characterization of SPP1-Expressing Macrophages and Their Predicted Interactions With T Cells in the Breast Cancer Bone Metastatic Microenvironment.Cancer reports (Hoboken, N.J.)
  • Non-invasive electromagnetic fields induce anti-tumor neutrophil reprogramming and enhance checkpoint blockade in breast cancer.Frontiers in immunology
  • Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Study design of the phase III ADELA trial of elacestrant with or without everolimus in ESR1-mutated ER+/HER2- advanced breast cancer after progression on endocrine therapy plus a CDK4/6 inhibitor.Future oncology (London, England)
  • Case reportMetastatic ductal carcinoma concealed within poorly differentiated thyroid carcinoma: Case report and literature review.Indian journal of pathology & microbiology
  • Patient frustration with time spent on advanced ovarian and metastatic breast cancer care.Gynecologic oncology reports
  • Meta-analysisPrognosis and therapeutic choices for occult breast cancer in female patients: a systematic review and meta-analysis.BMC surgery
  • Assessment of Metastatic Dissemination in Mouse Breast Carcinoma Models Using Magnetic Resonance Imaging (MRI).Methods in molecular biology (Clifton, N.J.)
  • MCOLN2 (Mucolipin-2) promotes autophagy to confer Adriamycin resistance in breast cancer by regulating mTOR degradation.Cellular oncology (Dordrecht, Netherlands)
  • ReviewDrugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer.European journal of cancer (Oxford, England : 1990)
  • Real-world comparative outcomes of pyrotinib-based versus pertuzumab-based first-line therapy in HER2-Positive advanced breast cancer: a multicenter retrospective cohort study from Xinjiang, China.Frontiers in pharmacology
  • Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India.Breast cancer research and treatment
  • Randomised trialReal-Time Electronic Patient-Reported Outcome Monitoring With Digital Triage and Care-Team Integration in Early Breast Cancer: ENABLE Randomized Controlled Trial.Journal of medical Internet research
  • ReviewThe Current Landscape of Exosome-Based Strategies for Breast Cancer Brain Metastasis: From Mechanistic Insights to Therapeutic Potential.International journal of nanomedicine
  • Systematic reviewTumor lysis syndrome in breast cancer: a systematic review of the literature.Frontiers in oncology
  • Economic evaluation of pertuzumab in early versus late settings of HER2-positive breast cancer: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care
  • Observational studyClinicopathological features, prognostic factors and treatment outcome in male breast cancer: An observational retrospective study from tertiary cancer center.Journal of cancer research and therapeutics
  • Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.Breast cancer research and treatment
  • Biomimetic M1 macrophage Membrane-Modified liposomes Co-delivering ponatinib and ginsenoside Rg3 for inhibition of breast cancer lung metastasis.Journal of ginseng research
  • ReviewPost CDK4/6 inhibitors: Novel targeted combinations based on SERDs in HR+/HER2- advanced breast cancer.Acta pharmaceutica Sinica. B
  • To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.Breast (Edinburgh, Scotland)
  • Efficacy and safety of sacituzumab govitecan in metastatic breast cancer: a single-center retrospective cohort study.Frontiers in oncology
  • An Inverse-Selection-Probability Weighted Approach for Real-World Progression-Free Survival With Left-Truncated Clinico-Genomic Data.Pharmaceutical statistics
  • Predictive Value of Combined Ultrasound Viscoelasticity Imaging, CEUS, AAPR, and PLR for Assessing Neoadjuvant Chemotherapy Efficacy in Breast Cancer.Breast cancer (Dove Medical Press)